Researchers found no clear differences in terms of severe hypoglycemia incidence or A1C levels among adult nonpregnant individuals with type 2 diabetes who used short-acting insulin analogs or regular human insulin, according to a study in the Cochrane Database of Systematic Reviews. Findings were based on data from 10 randomized, controlled clinical trials involving 2,751 participants.
Research compares effects of insulin analogs, regular insulin
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.